PPW
FLNA

Pinnacle Private Wealth’s Filana Therapeutics FLNA Stock Holding History

Pinnacle Private Wealth’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-16,600
Closed -$617K – 305
2022
Q1 		$617K Hold
16,600
– – 0.19% 119
2021
Q4 		$725K Buy
+16,600
New +$871K 0.23% 110

Other funds holding FLNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Pinnacle Private Wealth's FLNA Position: Q2 2022 in Review

Pinnacle Private Wealth sold out of Filana Therapeutics (FLNA) in Q2 2022, closing a stake of 16,600 shares — an estimated $617K sold.

Pinnacle Private Wealth first reported a position in FLNA in Q4 2021 and held it in 2 quarters. The position peaked at $725K in Q4 2021. 149 funds tracked by Wall St. Rank hold FLNA as of Q2 2022.

  • Pinnacle Private Wealth reported no remaining Filana Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Pinnacle Private Wealth sold 16,600 Filana Therapeutics shares in Q2 2022, an estimated $617K.
  • Pinnacle Private Wealth first reported a position in Filana Therapeutics in Q4 2021 and held it in 2 quarters.
  • Pinnacle Private Wealth's Filana Therapeutics position peaked at $725K in Q4 2021.
  • 149 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2022.

Based on Pinnacle Private Wealth's 13F filing for Q2 2022, filed 15 Jul 2022.